FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target.

Yun, Wen-Jing; Zhang, Li; Yang, Ning; Cui, Zheng-Guo; Jiang, Hua-Mao; Ha, Min-Wen; Yu, Da-Yong; Zhao, Ming-Zhen; Zheng, Hua-Chuan

Yun, Wen-Jing; Zhang, Li; Yang, Ning; Cui, Zheng-Guo; Jiang, Hua-Mao; Ha, Min-Wen; Yu, Da-Yong; Zhao, Ming-Zhen; Zheng, Hua-Chuan.

Affiliation

Yun WJ; Department of Oncology and Central Laboratory, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Zhang L; Department of Oncology and Central Laboratory, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Yang N; Department of Oncology and Central Laboratory, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Cui ZG; Department of Environmental Health, University of Fukui School of Medical Sciences, Fukui, Japan.
Jiang HM; Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Ha MW; Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Yu DY; Department of Cell Biology, Basic Medical College of Chengde Medical University, Chengde, China.
Zhao MZ; Department of Oncology and Central Laboratory, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Zheng HC; Department of Oncology and Central Laboratory, The Affiliated Hospital of Chengde Medical University, Chengde, China.

Drug Dev Res ; 84(7): 1537-1552, 2023 11.

Article in En | MEDLINE | ID: mdl-37571819

Subject(s)
Key words

FAM64A; aggressiveness; gastric cancer; prognosis; target therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms Limits: Humans Language: En Journal: Drug Dev Res Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google